Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;20(4):e124036.
doi: 10.5812/ijem-124036. eCollection 2022 Oct.

Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

Anna Alieva  1 , Anvar Alimov  2 , Feruza Khaidarova  3 , Saidiganikhoja Ismailov  4 , Gulnara Rakhimova  5 , Dilorom Nazhmutdinova  6 , Barno Shagazatova  7 , Victoria Tsareva  8
Affiliations

Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

Anna Alieva et al. Int J Endocrinol Metab. .

Abstract

Background: Type 2 diabetes (T2D) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2D in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program for T2D.

Objectives: The current study, taking into account the limited resources of Uzbekistan's health care system, aimed to offer the most effective, simple, and economical option required for the actual implementation of regular T2D screening in the country's primary care.

Methods: The screening was conducted from December 2018 to March 2019. There were four different scenarios, which differed in terms of eligibility criteria and the methodology adopted for detecting dysglycemia.

Results: A total of 2,430 patients were examined in four months. The T2D diagnosis was established by an endocrinologist in 9.3% of the cases with one eligibility criterion and 15.9% of the cases with three eligibility criteria. The diagnosis of T2D was established by an endocrinologist in 11.7% of the cases with HbA1c screening and 13.5% of the cases with glucose screening.

Conclusions: The screening was feasible in Uzbekistan only in limited conditions. The reasonable strategy was found to be the screening for incidental glycemia in all patients with at least one T2D risk factor. It was recommended that patients with incidental glycemia ≥ 7.8 mmol/L should be tested for fasting glycemia.

Keywords: Low-income Countries; T2DM; T2DM Screening; Type 2 Diabetes Mellitus; Uzbekistan.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests: AA reports writing assistance was provided by Medical Advisers Group. AA reports a relationship with Republican Specialized Scientific-and-Practical Medical Center of Endocrinology named after academician Ya. Kh. Turakulov that includes: Employment. AA has patent issued to assignee. Other authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.. Screening scenarios studied for T2D
See this image and copyright information in PMC

References

    1. International Diabetes Federation . IDF Atlas 9th edition and other resources . Brussels: International Diabetes Federation; 2021. [cited 2021 Sep 7]. Available from: https://diabetesatlas.org/en/resources/
    1. Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387(10027):1513–30. doi: 10.1016/s0140-6736(16)00618-8. - DOI - PMC - PubMed
    1. Ali MK, Siegel KR, Chandrasekar E, Tandon N, Montoya PA, Mbanya JC, et al. Diabetes: An Update on the Pandemic and Potential Solutions. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2017. pp. 209–34. - DOI - PubMed
    1. Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 2019;16(3):e1002751. doi: 10.1371/journal.pmed.1002751. - DOI - PMC - PubMed
    1. Lee E. Diabetes: Screening, Diagnosis, and Prevention of Type 2 Diabetes. FP Essent. 2021;504:16–21. - PubMed

LinkOut - more resources